BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu CK, Chang KC, Tseng PL, Lu SN, Chen CH, Wang JH, Lee CM, Lin MT, Yen YH, Hung CH, Hu TH. Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels. PLoS One 2016;11:e0142378. [PMID: 26968010 DOI: 10.1371/journal.pone.0142378] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Huang CM, Chang KC, Hung CH, Chiu KW, Lu SN, Wang JH, Chen CH, Kee KM, Kuo YH, Tsai MC, Tseng PL, Lin MT, Wu CK, Hu TH, Cho CL, Yen YH. Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C. PLoS One 2017;12:e0182204. [PMID: 28797039 DOI: 10.1371/journal.pone.0182204] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Schmilovitz-Weiss H, Gingold-Belfer R, Grossman A, Issa N, Boltin D, Beloosesky Y, Morag Koren N, Meyerovitch J, Weiss A. Lowering the upper limit of serum alanine aminotransferase levels may reveal significant liver disease in the elderly. PLoS One 2019;14:e0212737. [PMID: 30973940 DOI: 10.1371/journal.pone.0212737] [Reference Citation Analysis]
3 Li Y, Wang J, Wang J, Xiao Y, Xu B, Li H, Yang L, Hao X, Ma Y. SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China. Virol J 2017;14:62. [PMID: 28335783 DOI: 10.1186/s12985-017-0708-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]